Baudax Bio, Inc.

ANJESO

Manufacturer:

Baudax Bio, Inc.

Anjeso HCPCS:

J1738

HCPCS Code Descriptor:

Injection, meloxicam, 1 mg

Category:

J Code

Anjeso NDCs:

71518-0001-01

Primary Type:

Non-Opiod Analgesic

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Anjeso CPT Codes:

Potential CPT administration codes for Anjeso can be found at the following link.

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

71518-0001-01

About Anjeso:

ANJESO is a Non-Opiod Analgesic drug manufactured by Baudax Bio, Inc. and administered via the Intravenous route of administration. The J Code: J1738 is aligned to the drug ANJESO.

ACCESS PRICING AND MORE BY REGISTERING

J1738 Added Date:

October 1, 2020

J1738 Effective Date:

October 1, 2020

J1738 Termination Date:

HCPCS Active

Anjeso billing and coding information can be found through Baudax Bio, Inc. at the link below:
Our team did not identify a source for Anjeso patient assistance information. Please reach out to our team if you feel that this is a mistake.
ANJESO prescribing information can be found at the link below:
Information regarding ANJESO’s side effects can be found at MedlinePlus